CD44 and liver cancer: By systematically optimizing the composition of the sterosome and the HA coating conditions, we sought to construct a nanocarrier that exhibits favorable physicochemical properties, enhanced biocompatibility, and selective uptake by CD44-overexpressing liver cancer cells.